Editas Medicine announced proof-of-concept data for a gene-editing approach for sickle cell disease that doesn't need a stem ...

An unfortunate reality is that life costs more when you are disabled. Why is this? Simply put, living with a disability often ...

Columnist and caregiver Sylvia Amuta shares the top pain management strategies that help her young cousin cope with sickle ...

Enrollment has finished for the Phase 3 RISE UP study, which is testing the oral therapy mitapivat in people with sickle cell ...

The FDA granted orphan drug status to Kind Pharmaceuticals' investigational oral small molecule AND017 to treat SCD.

Approved in India as Oxemia for anemia, desidustat stimulates erythropoietin, a signaling molecule secreted in response to ...

Women with SCD experience significant healthcare challenges, a study found, with researchers calling for training on ...

Mitem Pharma has acquired worldwide rights to Desferal (deferoxamine), a therapy commonly used to lower excessive and damaging iron levels induced by blood transfusions in people with sickle cell ...

Enlargement of the left atrium, one of the heart’s upper chambers, is associated with a greater sickle cell disease (SCD) burden for patients, with more emergency department visits and blood test ...

Preschool-aged children with sickle cell disease (SCD) living in so-called food deserts, or areas where access to healthy food is limited, and those without reliable transportation are at a higher ...

As I prepare to celebrate my 38th birthday on Oct. 18, I find myself lost in thought, reflecting on the incredible journey that has brought me to this milestone. Over the years, I’ve survived with ...